Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma

被引：0
|
作者：
Barr, Hallie
Dempsey, Jessica
Waller, Allyson
Huang, Ying
Williams, Nita
Sharma, Nidhi
Benson, Don M., Jr.
Rosko, Ashley E.
Efebera, Yvonne A.
Hofmeister, Craig C.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1889
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Daratumumab for the treatment of multiple myeloma
    Goldsmith, S. R.
    Foley, N.
    Schroeder, M. A.
    DRUGS OF TODAY, 2021, 57 (10) : 591 - 605
  • [22] Daratumumab: Beyond Multiple Myeloma
    Ejaz, Kiran
    Roback, John D.
    Stowell, Sean R.
    Sullivan, Harold C.
    TRANSFUSION MEDICINE REVIEWS, 2021, 35 (03) : 36 - 43
  • [23] Daratumumab for untreated multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (02): : E80 - E80
  • [24] The safety of daratumumab for the treatment of multiple myeloma
    Cejalvo, Maria J.
    Ribas, Paz
    de la Rubia, Javier
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 753 - 760
  • [25] Daratumumab improves survival in multiple myeloma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (11): : E480 - E480
  • [26] Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
    Palumbo, Antonio
    Chanan-Khan, Asher
    Weisel, Katja
    Nooka, Ajay K.
    Masszi, Tamas
    Beksac, Meral
    Spicka, Ivan
    Hungria, Vania
    Munder, Markus
    Mateos, Maria V.
    Mark, Tomer M.
    Qi, Ming
    Schecter, Jordan
    Amin, Himal
    Qin, Xiang
    Deraedt, William
    Ahmadi, Tahamtan
    Spencer, Andrew
    Sonneveld, Pieter
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08): : 754 - 766
  • [27] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1319 - 1331
  • [28] Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I
    McCord, J
    Nowak, RM
    McCullough, PA
    Foreback, C
    Borzak, S
    Tokarski, G
    Tomlanovich, MC
    Jacobsen, G
    Weaver, WD
    CIRCULATION, 2001, 104 (13) : 1483 - 1488
  • [29] NINE HUNDRED DARATUMUMAB INFUSIONS IN NINETY MINUTES FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE-CENTRE OBSERVATIONAL STUDY
    Attardi, E.
    Pilerci, S.
    Attucci, I.
    Buzzichelli, A.
    Messeri, M.
    Staderini, M.
    Vannucchi, A. M.
    Antonioli, E.
    HAEMATOLOGICA, 2021, 106 (10) : 91 - 91
  • [30] Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group
    Vozella, Federico
    Siniscalchi, A.
    Rizzo, M.
    Za, T.
    Antolino, G.
    Coppetelli, U.
    Piciocchi, A.
    Andriani, A.
    Annibali, O.
    De Rosa, L.
    Cimino, G.
    La Verde, G.
    De Stefano, V.
    Cantonetti, M.
    di Toritto, T. Caravita
    Petrucci, M. T.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 1059 - 1063
12345